Satellos Bioscience MSLE
NASDAQ MSLE
$6.75 -0.45 (-6.25%)
At close: Nov 11, 2026 · 4:00 PM EST

Satellos Bioscience (MSLE) EBIT (2025 - 2026)

Updated

Satellos Bioscience (MSLE) recorded EBIT of -$11.67 million in the quarter ended Jun 30, 2026, compared with -$5.58 million a year earlier.

Analysis

Satellos Bioscience (MSLE) EBIT (2025 - 2026) Analysis & Trends

On a TTM basis, Satellos Bioscience's EBIT came in at -$51.69 million as of Jun 30, 2026; for the year ended Dec 31, 2025, it came in at -$26.46 million.

  • Across earlier years, EBIT came in at -$19.91 million in the year ended Dec 31, 2024.
  • Quarterly EBIT has ranged from -$24.7 million in the quarter ended Dec 31, 2025 to $6.08 million in the quarter ended Mar 31, 2025 over the past five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 8.41 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 6.18 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 6.27 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 5.56 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 4.39 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 3.71 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 3.46 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 5.47 Bn
10 Satellos Bioscience 109.60 Mn -98.54 Mn - -11.67 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -11.67 Mn
Mar 31, 2026 -9.74 Mn
Jun 30, 2025 -5.58 Mn
Mar 31, 2025 -6.08 Mn
API Access

Satellos Bioscience EBIT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit&ticker=MSLE&period=max&api_key=YOUR_API_KEY